Department of Radiology

Publications

2019

Chaker S, Al-Dasuqi K, Baradaran H, Demetres M, Delgado D, Nehmeh S, et al. Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease. Stroke. 2019;50(8):2072-2079.

Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, et al. Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery. ACS Chem Neurosci. 2019;10(5):2287-2298.

Kim E, Mema E, Axelrod D, Sigmund E, Kim SG, Babb J, et al. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer. Eur J Radiol. 2019;110:163-168.

Glodzik L, Rusinek H, Tsui W, Pirraglia E, Kim H-, Deshpande A, et al. Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension. Hypertension. 2019;73(1):197-205.

Qiu W, Li D, Jin X, Liu F, Nguyen TD, Prince MR, et al. Sliding motion compensated low-rank plus sparse (SMC-LS) reconstruction for high spatiotemporal free-breathing liver 4D DCE-MRI. Magn Reson Imaging. 2019;58:56-66.

Zhang S, Liu Z, Nguyen TD, Yao Y, Gillen KM, Spincemaille P, et al. Clinical feasibility of brain quantitative susceptibility mapping. Magn Reson Imaging. 2019;60:44-51.

Parker DB, Razlighi QR. The Benefit of Slice Timing Correction in Common fMRI Preprocessing Pipelines. Front Neurosci. 2019;13:821.

Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, et al. Rapid automated liver quantitative susceptibility mapping. J Magn Reson Imaging. 2019;50(3):725-732.

Miyata M, Kakeda S, Toyoshima Y, Ide S, Okada K, Adachi H, et al. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease. Neuroradiology. 2019;61(11):1251-1259.

Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, et al. Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. J Nucl Med. 2019;60(12):1794-1801.